43 results
Page 2 of 3
6-K
EX-99.1
omf9 dwpulhybdz
30 Mar 22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
7:53am
6-K
EX-99.1
daf5b9il bt99i16p6
5 Jan 22
Current report (foreign)
9:03am
6-K
EX-99.1
qyqv3p 578
16 Nov 21
Current report (foreign)
4:05pm
6-K
EX-99.1
qd4s53z84
12 Nov 21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
12:00am
6-K
EX-99.1
yg2j0m ni14bew
8 Nov 21
Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner
4:55pm
6-K
EX-99.1
sy9rmz
9 Sep 21
Current report (foreign)
11:29am
6-K
EX-99.1
sljmfuotyoxkz
4 Aug 21
Current report (foreign)
7:17am
6-K
EX-99.1
7bq770
4 Aug 21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights
7:16am
6-K
EX-99.1
rdzk5saw en2ccbjov9r
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.1
yomdly7
28 Jun 21
Current report (foreign)
8:16am
6-K
EX-99.2
5uy4ubr2kxl 5cljkdw2
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
udkrkek5xva
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
0rgi6ib k1sca
13 Feb 20
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety
4:25pm
6-K
EX-99.1
6qk92fjmg tx
15 Nov 19
Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update
9:02am
6-K
EX-99.2
pwkto i3v6k
25 Jul 19
Current report (foreign)
6:02am
6-K
EX-99.1
7e6jq5mjua8vrs2i fo
23 Jul 19
Current report (foreign)
8:19am
6-K
EX-99.1
5klyaqpei25z9
8 Jul 19
Current report (foreign)
8:58am